Arjan Diepstra
Arjan Diepstra
Patholoog, UMC Groningen
Verified email at
Cited by
Cited by
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ...
Nature 471 (7338), 377-381, 2011
High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma
A Van den Berg, BJ Kroesen, K Kooistra, D de Jong, J Briggs, T Blokzijl, ...
Genes, Chromosomes and Cancer 37 (1), 20-28, 2003
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16. 1 (REL), 8q24. 21 and 10p14 (GATA3)
V Enciso-Mora, P Broderick, Y Ma, RF Jarrett, H Hjalgrim, K Hemminki, ...
Nature genetics 42 (12), 1126-1130, 2010
Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma
A Diepstra, M Niens, E Vellenga, GW Van Imhoff, IM Nolte, M Schaapveld, ...
The Lancet 365 (9478), 2216-2224, 2005
Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues
E Maggio, A van den Berg, A Diepstra, J Kluiver, L Visser, S Poppema
Annals of oncology 13, 52-56, 2002
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma
M Niens, RF Jarrett, B Hepkema, IM Nolte, A Diepstra, M Platteel, ...
Blood, The Journal of the American Society of Hematology 110 (9), 3310-3315, 2007
Genome-wide association study of classical Hodgkin lymphoma and Epstein–Barr virus status–defined subgroups
KY Urayama, RF Jarrett, H Hjalgrim, A Diepstra, Y Kamatani, A Chabrier, ...
Journal of the National Cancer Institute 104 (3), 240-253, 2012
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma
A Diepstra, GW van Imhoff, HE Karim-Kos, A van den Berg, ...
Journal of clinical oncology 25 (21), 3101-3108, 2007
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes
Y Ma, L Visser, H Roelofsen, M de Vries, A Diepstra, G van Imhoff, ...
Blood, The Journal of the American Society of Hematology 111 (4), 2339-2346, 2008
Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma
C Steidl, A Diepstra, T Lee, FC Chan, P Farinha, K Tan, A Telenius, ...
Blood, The Journal of the American Society of Hematology 120 (17), 3530-3540, 2012
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
M Niens, L Visser, IM Nolte, G Van Der Steege, A Diepstra, P Cordano, ...
British journal of haematology 140 (5), 527-536, 2008
miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes
LP Tan, M Wang, JL Robertus, RN Schakel, JH Gibcus, A Diepstra, ...
Laboratory investigation 89 (6), 708-716, 2009
The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component
Y Liu, A Sattarzadeh, A Diepstra, L Visser, A van den Berg
Seminars in cancer biology 24, 15-22, 2014
Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy
GP Basadonna, L Auersvald, CQ Khuong, XX Zheng, N Kashio, D Zekzer, ...
Proceedings of the National Academy of Sciences 95 (7), 3821-3826, 1998
Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin’s lymphoma predicts adverse outcome in older adult patients
A Diepstra, GW van Imhoff, M Schaapveld, H Karim-Kos, A van den Berg, ...
J Clin Oncol 27 (23), 3815-21, 2009
Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma
A van den Berg, E Maggio, R Rust, K Kooistra, A Diepstra, S Poppema
Blood, The Journal of the American Society of Hematology 100 (4), 1425-1429, 2002
HLA‐G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma
A Diepstra, S Poppema, M Boot, L Visser, IM Nolte, M Niens, ...
Tissue antigens 71 (3), 219-226, 2008
A meta-analysis of Hodgkin lymphoma reveals 19p13. 3 TCF3 as a novel susceptibility locus
W Cozen, MN Timofeeva, D Li, A Diepstra, D Hazelett, ...
Nature communications 5 (1), 1-10, 2014
HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
M Nijland, RN Veenstra, L Visser, C Xu, K Kushekhar, GW van Imhoff, ...
Oncoimmunology 6 (4), e1295202, 2017
The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing
Y Liu, FR Abdul Razak, M Terpstra, FC Chan, A Saber, M Nijland, ...
Leukemia 28 (11), 2248-2251, 2014
The system can't perform the operation now. Try again later.
Articles 1–20